End Stage Kidney Disease: Clinical Trials

2 trials for End Stage Kidney Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Recruiting 1

Follow End Stage Kidney Disease: new trials by email Literature Review of End Stage Kidney Disease trials Research Report on End Stage Kidney Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
CSL300, Placebo - End Stage Kidney Disease
Phase 2 / Phase 3RecruitingCSL Behring31102024-04-272026-09-21
Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation
IdeS - End Stage Kidney Disease
Phase 2CompletedHansa Biopharma AB102015-06-012018-01-08

Narrower conditions

Kidney Failure, Chronic (2)  ·  Atherosclerosis (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)  ·  Myocardial Infarction (1)  ·  Peripheral Arterial Disease (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Renal Insufficiency (2)  ·  Renal Insufficiency, Chronic (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)

Interventions

clazakizumab (1)

Sponsors

CSL Behring (1)  ·  Hansa Biopharma AB (1)

Countries

Sweden (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hong Kong (1)

Top investigators

Lena Winstedt, PhD (1)

Results publications

PMID 28767349, PMID 37322595, PMID 38796655